Evidence map›Paper›PMID 20219449›Full record

ArticleChemico-biological interactions2010

The concept of pharmacologic cocaine interception as a treatment for drug abuse.

Yang Gao, Frank M Orson, Berma Kinsey, Tom Kosten, Stephen Brimijoin

Abstract read
In one paragraph

Article in Chemico-biological interactions, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Catalytic Antibody Blunts Carfentanil-Induced Respiratory Depression.ACS pharmacology & translational science · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Plasma butyrylcholinesterase regulates ghrelin to control aggression.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  8. The future potential for cocaine vaccines.Expert opinion on biological therapy · 2014
    Review
  9. Vaccines against drugs of abuse: where are we now?Therapeutic advances in vaccines · 2014
    Review
  10. Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Cocaine hydrolase gene therapy for cocaine abuse.Future medicinal chemistry · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yang GaoMolecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Frank M Orson
Berma Kinsey
Tom Kosten
Stephen Brimijoin

Funding

Development of a Human Hydrolase to Treat Cocaine Abuse and Overdose:Rat ModelsR01DA023979 · NIDA · MAYO CLINIC ROCHESTER · PI BRIMIJOIN, WILLIAM STEPHEN · 2007 to 2011
$2.3M
Development of Novel Vaccines for Cocaine AbuseR01DA030338 · NIDA · METHODIST HOSPITAL RESEARCH INSTITUTE · PI ORSON, FRANK M, WANG, RONGFU · 2010 to 2014
$1.6M
NIDA NIH HHS R01 DA023979NIDA NIH HHS R01 DA030338NIDA NIH HHS R01 DA23979Z-03S1
6 · The paper itself

Abstract

Cocaine access to brain tissue and associated cocaine-induced behaviors are substantially reduced in rats and mice by significant plasma levels of an enzyme that rapidly metabolizes the drug. Similar results have been obtained in rodents and humans with therapeutic anti-cocaine antibodies, which sequester the drug and prevent its entry into the brain. We show that an efficient cocaine hydrolase can lead to rapid unloading of anti-cocaine antibodies saturated with cocaine, and we provide a theoretical basis for the hypothesis that dual therapy with antibody and hydrolase enzyme may be especially effective.

Indexed as

AnimalsAntibodiesBiological TransportBrainCocaineDrug Therapy, CombinationHumansHydrolasesHydrolysisMiceRatsRewardSubstance-Related DisordersAntibodiesCocaineHydrolases

Identifiers

PMID20219449
PMCPMC2895017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.